The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Adenovirus Diagnostic Testing Market Research Report 2024
Synopsis
The global Adenovirus Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Adenovirus Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adenovirus Diagnostic Testing.
Report Scope
The Adenovirus Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Adenovirus Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adenovirus Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Danaher
BioMerieux
Ortho Clinical Diagnostics
Roche
SiemensHealthineers
Tosoh
GSKBiologicals
ThermoFisher
Affymetrix
BectonDickinson
BioRad
Cepheid
Diamedix
DiaSorin
Fujirebio
Grifols
Hologic
Lonza
PerkinElmer
Qiagen
Scienion
Sequenom
SeraCare
Wako
Segment by Type
Imaging Test
Respiratory Measurement
Bloodgas Test
Other
Segment by Application
Hospitals
Specialty Clinics
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adenovirus Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Adenovirus Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Adenovirus Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adenovirus Diagnostic Testing.
Report Scope
The Adenovirus Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Adenovirus Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adenovirus Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Danaher
BioMerieux
Ortho Clinical Diagnostics
Roche
SiemensHealthineers
Tosoh
GSKBiologicals
ThermoFisher
Affymetrix
BectonDickinson
BioRad
Cepheid
Diamedix
DiaSorin
Fujirebio
Grifols
Hologic
Lonza
PerkinElmer
Qiagen
Scienion
Sequenom
SeraCare
Wako
Segment by Type
Imaging Test
Respiratory Measurement
Bloodgas Test
Other
Segment by Application
Hospitals
Specialty Clinics
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adenovirus Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adenovirus Diagnostic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Imaging Test
1.2.3 Respiratory Measurement
1.2.4 Bloodgas Test
1.2.5 Other
1.3 Market by Application
1.3.1 Global Adenovirus Diagnostic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adenovirus Diagnostic Testing Market Perspective (2019-2030)
2.2 Adenovirus Diagnostic Testing Growth Trends by Region
2.2.1 Global Adenovirus Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Adenovirus Diagnostic Testing Historic Market Size by Region (2019-2024)
2.2.3 Adenovirus Diagnostic Testing Forecasted Market Size by Region (2025-2030)
2.3 Adenovirus Diagnostic Testing Market Dynamics
2.3.1 Adenovirus Diagnostic Testing Industry Trends
2.3.2 Adenovirus Diagnostic Testing Market Drivers
2.3.3 Adenovirus Diagnostic Testing Market Challenges
2.3.4 Adenovirus Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adenovirus Diagnostic Testing Players by Revenue
3.1.1 Global Top Adenovirus Diagnostic Testing Players by Revenue (2019-2024)
3.1.2 Global Adenovirus Diagnostic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Adenovirus Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adenovirus Diagnostic Testing Revenue
3.4 Global Adenovirus Diagnostic Testing Market Concentration Ratio
3.4.1 Global Adenovirus Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adenovirus Diagnostic Testing Revenue in 2023
3.5 Adenovirus Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Adenovirus Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Adenovirus Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adenovirus Diagnostic Testing Breakdown Data by Type
4.1 Global Adenovirus Diagnostic Testing Historic Market Size by Type (2019-2024)
4.2 Global Adenovirus Diagnostic Testing Forecasted Market Size by Type (2025-2030)
5 Adenovirus Diagnostic Testing Breakdown Data by Application
5.1 Global Adenovirus Diagnostic Testing Historic Market Size by Application (2019-2024)
5.2 Global Adenovirus Diagnostic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Adenovirus Diagnostic Testing Market Size (2019-2030)
6.2 North America Adenovirus Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Adenovirus Diagnostic Testing Market Size by Country (2019-2024)
6.4 North America Adenovirus Diagnostic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adenovirus Diagnostic Testing Market Size (2019-2030)
7.2 Europe Adenovirus Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Adenovirus Diagnostic Testing Market Size by Country (2019-2024)
7.4 Europe Adenovirus Diagnostic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adenovirus Diagnostic Testing Market Size (2019-2030)
8.2 Asia-Pacific Adenovirus Diagnostic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Adenovirus Diagnostic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Adenovirus Diagnostic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adenovirus Diagnostic Testing Market Size (2019-2030)
9.2 Latin America Adenovirus Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Adenovirus Diagnostic Testing Market Size by Country (2019-2024)
9.4 Latin America Adenovirus Diagnostic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adenovirus Diagnostic Testing Market Size (2019-2030)
10.2 Middle East & Africa Adenovirus Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Adenovirus Diagnostic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Adenovirus Diagnostic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Adenovirus Diagnostic Testing Introduction
11.1.4 Abbott Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher Adenovirus Diagnostic Testing Introduction
11.2.4 Danaher Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.2.5 Danaher Recent Development
11.3 BioMerieux
11.3.1 BioMerieux Company Detail
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Adenovirus Diagnostic Testing Introduction
11.3.4 BioMerieux Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.3.5 BioMerieux Recent Development
11.4 Ortho Clinical Diagnostics
11.4.1 Ortho Clinical Diagnostics Company Detail
11.4.2 Ortho Clinical Diagnostics Business Overview
11.4.3 Ortho Clinical Diagnostics Adenovirus Diagnostic Testing Introduction
11.4.4 Ortho Clinical Diagnostics Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.4.5 Ortho Clinical Diagnostics Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Adenovirus Diagnostic Testing Introduction
11.5.4 Roche Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.5.5 Roche Recent Development
11.6 SiemensHealthineers
11.6.1 SiemensHealthineers Company Detail
11.6.2 SiemensHealthineers Business Overview
11.6.3 SiemensHealthineers Adenovirus Diagnostic Testing Introduction
11.6.4 SiemensHealthineers Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.6.5 SiemensHealthineers Recent Development
11.7 Tosoh
11.7.1 Tosoh Company Detail
11.7.2 Tosoh Business Overview
11.7.3 Tosoh Adenovirus Diagnostic Testing Introduction
11.7.4 Tosoh Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.7.5 Tosoh Recent Development
11.8 GSKBiologicals
11.8.1 GSKBiologicals Company Detail
11.8.2 GSKBiologicals Business Overview
11.8.3 GSKBiologicals Adenovirus Diagnostic Testing Introduction
11.8.4 GSKBiologicals Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.8.5 GSKBiologicals Recent Development
11.9 ThermoFisher
11.9.1 ThermoFisher Company Detail
11.9.2 ThermoFisher Business Overview
11.9.3 ThermoFisher Adenovirus Diagnostic Testing Introduction
11.9.4 ThermoFisher Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.9.5 ThermoFisher Recent Development
11.10 Affymetrix
11.10.1 Affymetrix Company Detail
11.10.2 Affymetrix Business Overview
11.10.3 Affymetrix Adenovirus Diagnostic Testing Introduction
11.10.4 Affymetrix Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.10.5 Affymetrix Recent Development
11.11 BectonDickinson
11.11.1 BectonDickinson Company Detail
11.11.2 BectonDickinson Business Overview
11.11.3 BectonDickinson Adenovirus Diagnostic Testing Introduction
11.11.4 BectonDickinson Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.11.5 BectonDickinson Recent Development
11.12 BioRad
11.12.1 BioRad Company Detail
11.12.2 BioRad Business Overview
11.12.3 BioRad Adenovirus Diagnostic Testing Introduction
11.12.4 BioRad Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.12.5 BioRad Recent Development
11.13 Cepheid
11.13.1 Cepheid Company Detail
11.13.2 Cepheid Business Overview
11.13.3 Cepheid Adenovirus Diagnostic Testing Introduction
11.13.4 Cepheid Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.13.5 Cepheid Recent Development
11.14 Diamedix
11.14.1 Diamedix Company Detail
11.14.2 Diamedix Business Overview
11.14.3 Diamedix Adenovirus Diagnostic Testing Introduction
11.14.4 Diamedix Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.14.5 Diamedix Recent Development
11.15 DiaSorin
11.15.1 DiaSorin Company Detail
11.15.2 DiaSorin Business Overview
11.15.3 DiaSorin Adenovirus Diagnostic Testing Introduction
11.15.4 DiaSorin Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.15.5 DiaSorin Recent Development
11.16 Fujirebio
11.16.1 Fujirebio Company Detail
11.16.2 Fujirebio Business Overview
11.16.3 Fujirebio Adenovirus Diagnostic Testing Introduction
11.16.4 Fujirebio Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.16.5 Fujirebio Recent Development
11.17 Grifols
11.17.1 Grifols Company Detail
11.17.2 Grifols Business Overview
11.17.3 Grifols Adenovirus Diagnostic Testing Introduction
11.17.4 Grifols Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.17.5 Grifols Recent Development
11.18 Hologic
11.18.1 Hologic Company Detail
11.18.2 Hologic Business Overview
11.18.3 Hologic Adenovirus Diagnostic Testing Introduction
11.18.4 Hologic Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.18.5 Hologic Recent Development
11.19 Lonza
11.19.1 Lonza Company Detail
11.19.2 Lonza Business Overview
11.19.3 Lonza Adenovirus Diagnostic Testing Introduction
11.19.4 Lonza Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.19.5 Lonza Recent Development
11.20 PerkinElmer
11.20.1 PerkinElmer Company Detail
11.20.2 PerkinElmer Business Overview
11.20.3 PerkinElmer Adenovirus Diagnostic Testing Introduction
11.20.4 PerkinElmer Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.20.5 PerkinElmer Recent Development
11.21 Qiagen
11.21.1 Qiagen Company Detail
11.21.2 Qiagen Business Overview
11.21.3 Qiagen Adenovirus Diagnostic Testing Introduction
11.21.4 Qiagen Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.21.5 Qiagen Recent Development
11.22 Scienion
11.22.1 Scienion Company Detail
11.22.2 Scienion Business Overview
11.22.3 Scienion Adenovirus Diagnostic Testing Introduction
11.22.4 Scienion Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.22.5 Scienion Recent Development
11.23 Sequenom
11.23.1 Sequenom Company Detail
11.23.2 Sequenom Business Overview
11.23.3 Sequenom Adenovirus Diagnostic Testing Introduction
11.23.4 Sequenom Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.23.5 Sequenom Recent Development
11.24 SeraCare
11.24.1 SeraCare Company Detail
11.24.2 SeraCare Business Overview
11.24.3 SeraCare Adenovirus Diagnostic Testing Introduction
11.24.4 SeraCare Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.24.5 SeraCare Recent Development
11.25 Wako
11.25.1 Wako Company Detail
11.25.2 Wako Business Overview
11.25.3 Wako Adenovirus Diagnostic Testing Introduction
11.25.4 Wako Revenue in Adenovirus Diagnostic Testing Business (2019-2024)
11.25.5 Wako Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Adenovirus Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Imaging Test
Table 3. Key Players of Respiratory Measurement
Table 4. Key Players of Bloodgas Test
Table 5. Key Players of Other
Table 6. Global Adenovirus Diagnostic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Adenovirus Diagnostic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Adenovirus Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Adenovirus Diagnostic Testing Market Share by Region (2019-2024)
Table 10. Global Adenovirus Diagnostic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Adenovirus Diagnostic Testing Market Share by Region (2025-2030)
Table 12. Adenovirus Diagnostic Testing Market Trends
Table 13. Adenovirus Diagnostic Testing Market Drivers
Table 14. Adenovirus Diagnostic Testing Market Challenges
Table 15. Adenovirus Diagnostic Testing Market Restraints
Table 16. Global Adenovirus Diagnostic Testing Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Adenovirus Diagnostic Testing Market Share by Players (2019-2024)
Table 18. Global Top Adenovirus Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adenovirus Diagnostic Testing as of 2023)
Table 19. Ranking of Global Top Adenovirus Diagnostic Testing Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Adenovirus Diagnostic Testing Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Adenovirus Diagnostic Testing Product Solution and Service
Table 23. Date of Enter into Adenovirus Diagnostic Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Adenovirus Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Adenovirus Diagnostic Testing Revenue Market Share by Type (2019-2024)
Table 27. Global Adenovirus Diagnostic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Adenovirus Diagnostic Testing Revenue Market Share by Type (2025-2030)
Table 29. Global Adenovirus Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Adenovirus Diagnostic Testing Revenue Market Share by Application (2019-2024)
Table 31. Global Adenovirus Diagnostic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Adenovirus Diagnostic Testing Revenue Market Share by Application (2025-2030)
Table 33. North America Adenovirus Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Adenovirus Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Adenovirus Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Adenovirus Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Adenovirus Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Adenovirus Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Adenovirus Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Adenovirus Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Adenovirus Diagnostic Testing Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Adenovirus Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Adenovirus Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Adenovirus Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Adenovirus Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Adenovirus Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Adenovirus Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 48. Abbott Company Detail
Table 49. Abbott Business Overview
Table 50. Abbott Adenovirus Diagnostic Testing Product
Table 51. Abbott Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. Danaher Company Detail
Table 54. Danaher Business Overview
Table 55. Danaher Adenovirus Diagnostic Testing Product
Table 56. Danaher Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 57. Danaher Recent Development
Table 58. BioMerieux Company Detail
Table 59. BioMerieux Business Overview
Table 60. BioMerieux Adenovirus Diagnostic Testing Product
Table 61. BioMerieux Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 62. BioMerieux Recent Development
Table 63. Ortho Clinical Diagnostics Company Detail
Table 64. Ortho Clinical Diagnostics Business Overview
Table 65. Ortho Clinical Diagnostics Adenovirus Diagnostic Testing Product
Table 66. Ortho Clinical Diagnostics Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 67. Ortho Clinical Diagnostics Recent Development
Table 68. Roche Company Detail
Table 69. Roche Business Overview
Table 70. Roche Adenovirus Diagnostic Testing Product
Table 71. Roche Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 72. Roche Recent Development
Table 73. SiemensHealthineers Company Detail
Table 74. SiemensHealthineers Business Overview
Table 75. SiemensHealthineers Adenovirus Diagnostic Testing Product
Table 76. SiemensHealthineers Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 77. SiemensHealthineers Recent Development
Table 78. Tosoh Company Detail
Table 79. Tosoh Business Overview
Table 80. Tosoh Adenovirus Diagnostic Testing Product
Table 81. Tosoh Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 82. Tosoh Recent Development
Table 83. GSKBiologicals Company Detail
Table 84. GSKBiologicals Business Overview
Table 85. GSKBiologicals Adenovirus Diagnostic Testing Product
Table 86. GSKBiologicals Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 87. GSKBiologicals Recent Development
Table 88. ThermoFisher Company Detail
Table 89. ThermoFisher Business Overview
Table 90. ThermoFisher Adenovirus Diagnostic Testing Product
Table 91. ThermoFisher Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 92. ThermoFisher Recent Development
Table 93. Affymetrix Company Detail
Table 94. Affymetrix Business Overview
Table 95. Affymetrix Adenovirus Diagnostic Testing Product
Table 96. Affymetrix Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 97. Affymetrix Recent Development
Table 98. BectonDickinson Company Detail
Table 99. BectonDickinson Business Overview
Table 100. BectonDickinson Adenovirus Diagnostic Testing Product
Table 101. BectonDickinson Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 102. BectonDickinson Recent Development
Table 103. BioRad Company Detail
Table 104. BioRad Business Overview
Table 105. BioRad Adenovirus Diagnostic Testing Product
Table 106. BioRad Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 107. BioRad Recent Development
Table 108. Cepheid Company Detail
Table 109. Cepheid Business Overview
Table 110. Cepheid Adenovirus Diagnostic Testing Product
Table 111. Cepheid Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 112. Cepheid Recent Development
Table 113. Diamedix Company Detail
Table 114. Diamedix Business Overview
Table 115. Diamedix Adenovirus Diagnostic Testing Product
Table 116. Diamedix Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 117. Diamedix Recent Development
Table 118. DiaSorin Company Detail
Table 119. DiaSorin Business Overview
Table 120. DiaSorin Adenovirus Diagnostic Testing Product
Table 121. DiaSorin Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 122. DiaSorin Recent Development
Table 123. Fujirebio Company Detail
Table 124. Fujirebio Business Overview
Table 125. Fujirebio Adenovirus Diagnostic Testing Product
Table 126. Fujirebio Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 127. Fujirebio Recent Development
Table 128. Grifols Company Detail
Table 129. Grifols Business Overview
Table 130. Grifols Adenovirus Diagnostic Testing Product
Table 131. Grifols Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 132. Grifols Recent Development
Table 133. Hologic Company Detail
Table 134. Hologic Business Overview
Table 135. Hologic Adenovirus Diagnostic Testing Product
Table 136. Hologic Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 137. Hologic Recent Development
Table 138. Lonza Company Detail
Table 139. Lonza Business Overview
Table 140. Lonza Adenovirus Diagnostic Testing Product
Table 141. Lonza Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 142. Lonza Recent Development
Table 143. PerkinElmer Company Detail
Table 144. PerkinElmer Business Overview
Table 145. PerkinElmer Adenovirus Diagnostic Testing Product
Table 146. PerkinElmer Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 147. PerkinElmer Recent Development
Table 148. Qiagen Company Detail
Table 149. Qiagen Business Overview
Table 150. Qiagen Adenovirus Diagnostic Testing Product
Table 151. Qiagen Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 152. Qiagen Recent Development
Table 153. Scienion Company Detail
Table 154. Scienion Business Overview
Table 155. Scienion Adenovirus Diagnostic Testing Product
Table 156. Scienion Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 157. Scienion Recent Development
Table 158. Sequenom Company Detail
Table 159. Sequenom Business Overview
Table 160. Sequenom Adenovirus Diagnostic Testing Product
Table 161. Sequenom Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 162. Sequenom Recent Development
Table 163. SeraCare Company Detail
Table 164. SeraCare Business Overview
Table 165. SeraCare Adenovirus Diagnostic Testing Product
Table 166. SeraCare Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 167. SeraCare Recent Development
Table 168. Wako Company Detail
Table 169. Wako Business Overview
Table 170. Wako Adenovirus Diagnostic Testing Product
Table 171. Wako Revenue in Adenovirus Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 172. Wako Recent Development
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adenovirus Diagnostic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Adenovirus Diagnostic Testing Market Share by Type: 2023 VS 2030
Figure 3. Imaging Test Features
Figure 4. Respiratory Measurement Features
Figure 5. Bloodgas Test Features
Figure 6. Other Features
Figure 7. Global Adenovirus Diagnostic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Adenovirus Diagnostic Testing Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Diagnostic Centers Case Studies
Figure 12. Adenovirus Diagnostic Testing Report Years Considered
Figure 13. Global Adenovirus Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Adenovirus Diagnostic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Adenovirus Diagnostic Testing Market Share by Region: 2023 VS 2030
Figure 16. Global Adenovirus Diagnostic Testing Market Share by Players in 2023
Figure 17. Global Top Adenovirus Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adenovirus Diagnostic Testing as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Adenovirus Diagnostic Testing Revenue in 2023
Figure 19. North America Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Adenovirus Diagnostic Testing Market Share by Country (2019-2030)
Figure 21. United States Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Adenovirus Diagnostic Testing Market Share by Country (2019-2030)
Figure 25. Germany Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Adenovirus Diagnostic Testing Market Share by Region (2019-2030)
Figure 33. China Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Adenovirus Diagnostic Testing Market Share by Country (2019-2030)
Figure 41. Mexico Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Adenovirus Diagnostic Testing Market Share by Country (2019-2030)
Figure 45. Turkey Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Adenovirus Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Abbott Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 48. Danaher Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 49. BioMerieux Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 50. Ortho Clinical Diagnostics Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 51. Roche Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 52. SiemensHealthineers Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 53. Tosoh Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 54. GSKBiologicals Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 55. ThermoFisher Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 56. Affymetrix Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 57. BectonDickinson Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 58. BioRad Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 59. Cepheid Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 60. Diamedix Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 61. DiaSorin Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 62. Fujirebio Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 63. Grifols Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 64. Hologic Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 65. Lonza Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 66. PerkinElmer Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 67. Qiagen Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 68. Scienion Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 69. Sequenom Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 70. SeraCare Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 71. Wako Revenue Growth Rate in Adenovirus Diagnostic Testing Business (2019-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
